KENO PHARMA Risk Report
Generated on July 15, 2025
1
Risks
Summary
🏗️ Operational & Business Continuity
Keno Pharma might face risks related to the continuity of its business operations, influenced by its industry and geographic location. Operational continuity risks could impact the company's ability to maintain a stable production and supply chain, especially given the strategic importance of dual-use components they handle.
- China continues supplying Russia with critical dual-use components, which could implicate Keno Pharma's operational roles 🗓 September 24, 2024.
📜 Innovation & R&D
There is opportunity for Keno Pharma as they continue to invest in innovation and research, a critical aspect for growth in the pharmaceutical manufacturing sector. Advances in innovation may lead to new product development and enhanced market competitiveness.
- The development of strategies and optimal control analysis for malaria transmission highlighted Keno Pharma's innovative approach in using climate variability modeling 🗓 December 2, 2022.
News & Media
Stay informed with real-time news signals across financial, legal, and operational domains.
Profile
Specialties
Фармацевтика, ампулы, глазные капли, колпачок, минимальные сроки поставок, набор для упаковки лекарственных средств, нормы качества GPM, пакеты для инфузионных растворов, поставки, пробка, пусконаладочные работы, расходные материалы, сервисное обслуживание, соответсвие ISO, соответсвие ГОСТ, спрейеры, стеклодрот, строительство фармацевтических заводов, субстанции, тубы, узлы, упаковочные материалы, фармацевтическое оборудование, флаконы, химия